Fidelity Disruptive Medicine ETF FMED
32.05 USD +0.46 (+1.47%)
At closeNov 3, 2026, 4:00 PM EST
31.99 -0.06 -0.19%
After hours · Nov 3, 4:00 PM ET
31.75 Day range 32.37
23.48 52-week range 33.56
- YTD
- +18.48%
- 1 year
- +23.22%
- Market cap
- 73.28M
- EPS (ttm)
- 0.705577
- P/E ratio
- 45.42
- YTD return
- +18.48%
- 1-year return
- +23.22%
- Volume
- 12.20K
- Avg volume
- 8.43K
- Open
- 31.75
- Previous close
- 31.59
- Day's range
- 31.75 – 32.37
- 52-week range
- 23.48 – 33.56
2Y +6.22 (+24.08%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 25.84
- 200-day average
- 25.06
About Fidelity Disruptive Medicine ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on FMED — it syncs with the Stock Master app.